Analytical Data
-
基因名
HSH2D
- Application
-
别名
Adaptor in lymphocytes of unknown function X; ALX ; FLJ14886; hematopoietic SH2 domain containing; Hematopoietic SH2 domain containing protein; Hematopoietic SH2 domain-containing protein; Hematopoietic SH2 protein; HSH2 ; Hsh2d; HSH2D_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96JZ2
-
表达区间
1-352aa
-
氨基酸序列
MTEAGKLPLPLPPRLDWFVHTQMGQLAQDGVPEWFHGAISREDAENLLESQPLGSFLIRVSHSHVGYTLSYKAQSSCCHFMVKLLDDGTFMIPGEKVAHTSLDALVTFHQQKPIEPRRELLTQPCRQKDPANVDYEDLFLYSNAVAEEAACPVSAPEEASPKPVLCHQSKERKPSAEMNRITTKEATSSCPPKSPLGETRQKLWRSLKMLPERGQRVRQQLKSHLATVNLSSLLDVRRSTVISGPGTGKGSQDHSGDPTSGDRGYTDPCVATSLKSPSQPQAPKDRKVPTRKAERSVSCIEVTPGDRSWHQMVVRALSSQESKPEHQGLAEPENDQLPEEYQQPPPFAPGYC
-
分子量
64.46 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant E.coli eptA Protein，His
Cat：PA2000-4230
Recombinant Human AMY1A Protein，His
Cat：PA2000-158DB
Protein Description
HSH2D, or Heterogeneous Nuclear Ribonucleoprotein H2D, is a reprogrammed protein that plays a critical role in various cellular processes, including RNA processing and gene regulation. The study of HSH2D has gained attention due to its involvement in essential biological functions and its potential implications in disease mechanisms, particularly in cancer and neurodegenerative disorders. As a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family, HSH2D is known for its ability to bind pre-mRNA and influence splicing, stability, and transport of RNA molecules. Advances in molecular biology and genetic engineering techniques have enabled researchers to investigate the structural and functional characteristics of HSH2D, aiming to uncover its specific roles in cellular metabolism and its interactions with other regulatory proteins. Understanding the intricate workings of HSH2D can provide insights into how dysregulation of RNA synthesis and processing contributes to disease. Furthermore, the exploration of HSH2D as a potential biomarker or therapeutic target is a promising avenue, as it could lead to novel strategies for diagnosis and treatment. This growing interest underscores the importance of HSH2D in cellular biology and its relevance in biomedical research, supporting further investigation into its mechanisms and applications in health and disease.
